Insider Stock Trading History of Tananbaum James B.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tananbaum James B. since year 2005. The trader's CIK number is 1581754. At the time of this reporting, Tananbaum James B. is the 10% Owner of Aerie Pharmaceuticals Inc . (stock ticker symbol AERI). See this page for all insider trading activities at Aerie Pharmaceuticals Inc .

Note that in the past Tananbaum James B. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tananbaum James B. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-05-26 AERI Aerie Pharmaceuticals Inc Sale 20,000 55.95 1,119,000
2016-10-06 AERI Aerie Pharmaceuticals Inc Sale 50,000 40.34 2,017,000
2016-07-22 AERI Aerie Pharmaceuticals Inc Buy 250,000 17.50 4,375,000
2016-05-31 AIMT Aimmune Therapeutics, Inc. Sale 240,000 15.23 3,654,720
2015-08-24 AIMT Aimmune Therapeutics, Inc. Buy 25,485 19.66 500,907
2015-08-11 AIMT Aimmune Therapeutics, Inc. Buy 642,035 17.50 11,235,612
2013-06-12 AMBI Ambit Biosciences Corp Buy 5,700 7.45 42,482
2013-06-24 AMBI Ambit Biosciences Corp Buy 4,817 6.77 32,591
2013-05-17 AMBI Ambit Biosciences Corp Buy 36,616 6.77 247,963
2013-06-14 AMBI Ambit Biosciences Corp Buy 7,500 7.46 55,965
2013-06-03 AMBI Ambit Biosciences Corp Buy 10,000 6.99 69,910
2013-05-20 AMBI Ambit Biosciences Corp Buy 8,120 6.90 56,044
2013-05-21 AMBI Ambit Biosciences Corp Buy 1,811 6.84 12,379
2013-05-22 AMBI Ambit Biosciences Corp Buy 5,005 6.74 33,728

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tananbaum James B. (10% Owner of Aerie Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.